Acadia Pharmaceuticals reported $2.75B in Market Capitalization this August of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 2.28B 1.63B
ALKERMES ALKS:US 4.89B 0.63B
Alnylam Pharmaceuticals ALNY:US $ 17.65B 2.06B
Aptinyx Inc APTX:US $ 0.04B 0.12B
Biogen BIIB:US $ 29.87B 1.08B
Biomarin Pharmaceutical BMRN:US $ 15.33B 1.08B
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Cara Therapeutics CARA:US $ 0.49B 0.16B
Corcept Therapeutics CORT:US $ 2.53B 0.14B
Cytokinetics CYTK:US $ 3.36B 0.22B
Eisai 4523:JP 1697.85B 16.31B
Eli Lilly And LLY:US $ 308.07B 35.35B
Intercept Pharmaceuticals ICPT:US $ 0.41B 0.07B
Intra Cellular Therapies ITCI:US $ 5.38B 0.37B
Johnson & Johnson JNJ:US $ 467.1B 1.05B
Marinus Pharmaceuticals MRNS:US $ 0.18B 0.17B
Moderna Inc MRNA:US $ 56.82B 12.6B
Neurocrine Biosciences NBIX:US $ 9.32B 0.36B
Pfizer PFE:US $ 294.18B 1.79B
Prothena PRTA:US 1.27B 0.44B
Ptc Therapeutics PTCT:US $ 2.86B 0.2B
Sarepta Therapeutics SRPT:US $ 6.56B 0.25B
Seattle Genetics SGEN:US $ 32.57B 6.12B
Ultragenyx Pharmaceutical RARE:US $ 4.17B 0.87B
Vanda Pharmaceuticals VNDA:US $ 0.62B 0.02B
Vertex Pharmaceuticals VRTX:US $ 72.14B 5.45B
YTE INCY:US $ 16.83B 0.75B